9th Annual
EU Medical Device & Diagnostic Reimbursement & Market Access Conference
February 2-3, 2027 | Virtual Event
9th Annual
EU Medical Device & Diagnostic Reimbursement & Market Access Conference
February 2-3, 2027
Virtual Event
Align Evidence with HTA Expectations, Plan Market Access Early & Advance Reimbursement for AI-Based Technologies
Align Evidence with HTA Expectations, Plan Market Access Early & Advance Reimbursement for AI-Based Technologies
Program Overview
Medical device and diagnostic companies face an increasingly complex European landscape where regulatory clearance no longer guarantees commercial success. This virtual conference brings together MedTech leaders and market access specialists to explore strategies for aligning early evidence development with the requirements of European payers, assessment bodies, and health system purchasers. Sessions will cover reimbursement pathways for AI-driven technologies and novel devices, procurement barriers, and regional payment incentives. Attendees will compare cross-border evidence expectations, identify strategy gaps, and craft compelling value propositions that translate regulatory approval into funded adoption across key European healthcare systems.
The dynamic Q1 Productions virtual platform fosters a sense of collaboration. Thoughtfully designed networking features connect you with your peers beyond the capabilities of a Zoom meeting. Customize your experience and address your unique concerns during live Q&A after each session. Our commitment to industry perspectives keeps the program focused on what matters and dynamic session formats to increase interactivity and strategy-building.
Countdown to the EU Medical Device & Diagnostic Reimbursement & Market Access Conference:
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)











